Another study proposed that a chemokine expression signature allows classification of HNSCC into high and low CD8+ T cell-infiltrated tumor phenotypes (TCIP-H vs. TCIP-L) associated with different clinical outcome. The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.